New combo therapy shows promise for Hard-to-Treat cancers
NCT ID NCT02617277
First seen Nov 17, 2025 · Last updated May 15, 2026 · Updated 22 times
Summary
This early-phase study tested a new combination of two drugs, AZD1775 (a pill) and durvalumab (given by IV), in 56 adults with advanced solid tumours that had stopped responding to standard treatments. The main goal was to check the safety and side effects of the combination, and to see how the body processes the drugs. While not a cure, the study aimed to find a safe dose and gather early signs of tumour control.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOURS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Denver, Colorado, 80218, United States
-
Research Site
Sarasota, Florida, 34232, United States
-
Research Site
Nashville, Tennessee, 37203, United States
Conditions
Explore the condition pages connected to this study.